Showing results (851-860 of 2,363) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|February 25, 2016
Unveiling new chemical scaffolds as Mnk inhibitorsSarah Diab, Peng Li, Sunita K C Basnet, et al.
Future Medicinal Chemistry|October 1, 2015
Highlights from SelectBio 2015: Academic Drug Discovery Conference, Cambridge, UK, 19-20 May 2015John Spencer, Hannah Coaker
Future Medicinal Chemistry|October 3, 2015
Equisetin, reutericyclin and streptolodygin as natural product lead structures for novel antibiotic librariesYong-Chul Jeong, Mark G Moloney
Future Medicinal Chemistry|August 27, 2015
Immunogenicity and pharmacokinetics of short, proline-rich antimicrobial peptidesLuzia Holfeld, Nicole Herth, David Singer, et al.
Future Medicinal Chemistry|August 1, 2015
Pyrazin-2(1H)-ones as a novel class of selective A3 adenosine receptor antagonistsJhonny Azuaje, Carlos Carbajales, Manuel González-Gómez, et al.
Future Medicinal Chemistry|August 1, 2015
The promise of zebrafish as a chemical screening tool in cancer therapyXiayang Xie, James L Ross, John K Cowell, et al.
Future Medicinal Chemistry|August 1, 2015
Carbonic anhydrase IX inhibitors in cancer therapy: an updateClaudiu T Supuran, Jean-Yves Winum
Future Medicinal Chemistry|December 16, 2014
The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channelErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
Future Medicinal Chemistry|December 16, 2014
Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's diseaseOussama Cherif, Fatma Allouche, Fakher Chabchoub, et al.
Future Medicinal Chemistry|December 16, 2014
"Too little, too late?" Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?Stephen Griffin
Pageof 237